This study focuses on the formulation and evaluation of ginseng granules aimed at providing antidiabetic activity. Ginseng, a well-known medicinal herb, is recognized for its potential benefits in managing diabetes due to its bioactive compounds, such as ginsenosides. The research involved preparing granules using a standardized extract of ginseng, followed by rigorous evaluation of their physical and chemical properties, including flowability, compressibility, and stability. In vitro assays were conducted to assess the granules ability to inhibit α-glucosidase and the enzyme α-amylase is involved in the metabolism of carbs. Additionally, in vivo studies on diabetic rats were performed to observe the hypoglycaemic effects of the ginseng granules. The outcomes showed that the ginseng granules that were prepared had a notable amount of enzyme inhibitory action and successfully lowered blood sugar levels in rats with diabetes, indicating that they could be used as an adjunctive treatment for diabetes control. This formulation could offer a novel, practical approach to harnessing ginsengs antidiabetic properties.